EX-99.1 2 a05-3694_1ex99d1.htm EX-99.1

Exhibit 99.1

 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

 

Link to searchable text of slide shown above

 


 

Searchable text section of graphics shown above

 



 

Redefining
Service

 

[LOGO]

 

2005 UBS Global Healthcare Services Conference

John J. Arlotta, Chairman, President & CEO

February 16, 2005

 



 

[LOGO]

 

Forward-Looking Statements

 

Statements made in this presentation, our website and in our other public filings and releases, which are not historical facts contain “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time.  These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may”, “target” and similar expressions. Such forward looking statements include, without limitation, statements regarding the effect of the spin-off on our operations, expected changes in reimbursement rates and inflationary increases in state Medicaid rates, expected bed count, expected SG&A expense, anticipated restructuring charges and estimates of timing and costs savings related to cost improvement initiatives.  Factors that could cause actual results to differ materially include, but are not limited to, the following: our ability, and the ability of our customers, to comply with Medicare or Medicaid reimbursement regulations or other applicable laws, changes in the reimbursement rates or methods of payment from Medicare and Medicaid, or the implementation of other measures to reduce the reimbursement for our services and the impact of the Medicare Prescription Drug, Improvement and Modernization Act of 2003, changes in pharmacy legislation and payment formulas, the impact of federal and state regulations, competition in our businesses, the impact of Omnicare, Inc.’s unsolicited tender offer to acquire all of our outstanding common stock, competition for qualified management and pharmacy professionals, the impact of investigations and audits relating to alleged violations of federal and/or state regulations, changes in the acuity of patients, payor mix and payment methodologies, further consolidation of managed care organizations and other third party payors, the effect of the expiration or termination of certain service and supply contracts, changes in or our failure to satisfy pharmaceutical manufacturers’ rebate programs, an economic downturn or changes in the laws affecting our business in those markets in which we operate, the impact of acquisitions, and our ability to integrate acquired businesses, on our operations and finances, our ability to control operating costs and generate sufficient cash flow to meet operational and financial requirements, our ability, and the ability of our subsidiary guarantors, to fulfill debt obligations, our covenants and restrictions contained in financing agreements which limit our discretion in the operation of our business, our charter documents and the Pennsylvania Business Corporation Law of 1988, as amended, which could delay or prevent a change of control, availability of financial and other resources to us after the spin-off of GHC, operating inefficiencies and higher costs after the spin-off of GHC, federal income tax liabilities and indemnification obligations related to the spin-off of GHC, conflicts of interest as a result of our continuing relationship with GHC after the spin-off, the ability of GHC, as our largest customer, to operate as a separate entity and acts of God or public authorities, war, civil unrest, terrorism, fire, floods, earthquakes and other matters beyond our control.

 

The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control.  We caution investors that any forward-looking statements made by us are not guarantees of future performance.  We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

 



 

Company Overview
NeighborCare Business Segments

 

NeighborCare, Inc.

 

2004 Revenue

 

$

1.4

 

Billion

1Q05 Revenue

 

$

392

 

Million

 

INSTITUTIONAL PHARMACY

 

CORPORATE & OTHER

 

 

 

 

 

 

 

Retail Pharmacy

 

 

 

  32 Pharmacies in 4 states

 

 

 

  >1.5M scripts per year

  70 Pharmacies in 32 states + D.C.

 

 

 

 

NeighborCare At Home

~88% of 1Q05 Revenues

 

  17 Distribution centers in 9 states

 

 

  Home infusion, respiratory, medical

  287,249 Beds Served

 

equipment and hospice

 

 

 

  >30M scripts per year

 

Tidewater GPO

 

 

  Represents >550,00 beds

 

Note:  Data Ending F1Q05 

 



 

Company Overview
The Long-Term Care Pharmacy Business Cycle

 

Wholesaler delivers

NeighborCare delivers

drugs to NeighborCare

prescriptions to long-

Pharmacies

term care facilities

 

[CHART]

 



 

Company Overview
How NeighborCare Makes Money

 

[CHART]

 

Note: Numbers are an example, not intended to represent actual results

 



 

Company Overview
Historical Drug Trend

 

Components of Drug Trend

 

[CHART]

 

Source:  NeighborCare internal estimates and IMS study

 



 

Company Overview
NeighborCare Unique Value Proposition

 

 

 

      Runs on Laptop, Tablet or Web

 

 

      Physician Connectivity

 

 

      Drug Cost Projections

 

 

      Complete First Data Bank Data

[GRAPHIC]

 

      State PDL

 

 

      Facility Pricing

 

 

 

 

 

 

      Results Analysis

 

 

      Clinical Review Drug Compatibility

 

 

 

 

 

 

 

[LOGO]

 

 



 

Customer Tools:  inSightRxTM Reporting System

 

 

 

Sample Reports -

 

 

 

 

 

      Top 50 Medications

[GRAPHIC]

 

 

 

 

      Medicare A Drug Spend

 

 

 

 

 

      Physician Profiling

 

 

 

 

 

[LOGO]

 



 

Our Business Plan
Capitalizing on the Opportunity

 

                  Reduce service costs while improving customer service

 

                  Reduce product costs through improved formulary management

 

                  Grow sales organically and increase customer retention

 

                  Expand core business through acquisitions, new sites and sales force expansion to gain competitive advantage

 



 

Business Plan Update
Reduce Service Costs

 

                  Best demonstrated practices target achieved of $6M for 2004

                  Fax server implementation on schedule

                  Three sites evaluating paperless workflow

                  First component of automated “super pharmacy” ordered

 

Cost of Service As % of Revenue

 

[CHART]

 



 

Business Plan Update
Reduce Service Costs – Current Pharmacy Model

 

Full Service

 

[GRAPHIC]

Pharmacy Functions

 

[GRAPHIC]

Order Entry/Billing

 

 

[GRAPHIC]

Labels

 

 

[GRAPHIC]

Quality Control

 

 

[GRAPHIC]

Full Inventory

 

 

[GRAPHIC]

Customer Delivery

 

 

[GRAPHIC]

Professional Services

 



 

Business Plan Update
Reduce Service Costs – Example of Hub and Spoke Model

 

Pharmacy Functions

[GRAPHIC]

 

Hub

 

[GRAPHIC]

Order Entry/Billing

 

 

[GRAPHIC]

Labels

 

 

[GRAPHIC]

Quality Control

 

 

[GRAPHIC]

Full Inventory

 

 

[GRAPHIC]

Delivery to Customers & Spokes

 

 

[GRAPHIC]

Professional Services

 

Spoke

 

[GRAPHIC]

Emergency/First Dose inventory

 

 

[GRAPHIC]

Quality Control

 

 

[GRAPHIC]

Delivery to Customers

 



 

Business Plan Update
Reduce Service Costs – Drug Repack Center

 

[GRAPHIC]

 



 

Business Plan Update
Reduce Service Costs – Drug Repack Center

 

[GRAPHIC]

                  Currently in production

 

                  Pre-package unit dose

 

                  Operates under FDA cGMP standards

 

                  Unprecedented quality

 



 

Business Plan Update
Reduce Service Costs – Pharmacy Automation

 

                  Automation Objectives

 

                  Increase quality

                  Enhance service

                  Reduce dispensing costs

 

                  Integrate Proven Technology

 

                  Automatic labeling

                  Barcode verification

 

[GRAPHIC]

 



 

Business Plan Update
Reduce Product Costs

 

                  Significantly improved generic product costs

                  Generic spend currently at ~$90M annualized run rate

                  Updated contract with primary drug wholesaler

                  New tracking and diagnostic tools for formulary compliance

 

Rebates As % of Revenue

 

[CHART]

 



 

Business Plan Update
Reduce Product Costs - Improved Formulary Compliance

 

Sample Therapeutic Drug Class

 

[CHART]

 



 

Business Plan Update
Where NeighborCare Priority Programs Impact Profitability

 

[CHART]

 

                  Organic growth

                  Acquisitions

 

                  Brand & generic contracts

                  Wholesaler contract

                  Drug repack

                  Formulary compliance

 

                  BDPs

                  Consolidation/Hub & Spoke

                  Fax server

                  Paperless workflow

                  Drug repack

                  Pharmacy automation

 

                  Formulary compliance

 

                  Centralized real estate management

 

                  Interest rate swap

 

Note: Numbers are an example, not intended to represent actual results

 



 

Business Plan Update
Grow Sales Organically and Increase Customer Retention

 

                  Net organic bed growth in FY2004 and 1Q05 of 6,521 and 2,161

                  First year of positive net organic bed growth in four years

                  Reached retention rate goal for the full year

                  About 60% of new beds signed for 3 years or greater

 

Net Organic Bed Growth/Retention Rate

 

Retention Rate

 

~86

%

~87

%

~87

%

~88

%

~90

%

~90

%

 

[CHART]

 



 

Business Plan Update
Geographic Expansion – New Sites & Acquisitions

 

[GRAPHIC]

 



 

Medicare Modernization Act
Some Implications for Long Term Care

 

                  Too soon to drawn conclusions

 

                  Can’t predict the impact

 

                  More positive than negative

 

                  Formulary and rebates will be negotiated

 

                  Market will be very competitive

 



 

Financial Highlights

 

 

Any reference to non-GAAP financial information provided
herein is reconciled to comparable GAAP financial
information on our web site at
www.neighborcare.com/investor.

 



 

Financial Highlights
Historical Revenue Growth

 

Annual Revenue Growth

 

[CHART]

 

Note: Revenues have been adjusted to reflect the Genesis HealthCare intersegment revenue.

 



 

Financial Highlights
Increasing Beds Served and Revenue per Bed

 

Number of Beds Served

 

[CHART]

 

Avg. Revenue Per Bed Per Month

 

[CHART]

 



 

Financial Highlights
Days Sales Outstanding and Days Inventory

 

[CHART]

 



 

Financial Highlights
Cash Flow Highlights

 

 

 

For the Quarters Ended

 

($ in millions)

 

3/31/04

 

6/30/04

 

9/30/04

 

12/31/04

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

8.3

 

$

8.1

 

$

23.6

 

$

(22.5

)

 

 

 

 

 

 

 

 

 

 

Net cash used by investing activities

 

$

(10.9

)

$

(27.7

)

$

(9.5

)

$

(54.6

)

Capital expenditures

 

$

(7.0

)

$

(5.3

)

$

(9.5

)

$

(12.7

)

Acquisitions

 

$

(3.9

)

$

(22.4

)

 

$

(39.9

)

 

 

 

 

 

 

 

 

 

 

Net cash provided (used) by financing act.

 

$

1.2

 

$

(1.6

)

$

 (2.3

)

$

16.3

 

 

 

 

 

 

 

 

 

 

 

Cash and equivalents at end of period

 

$

91.3

 

$

70.1

 

$

81.9

 

$

21.1

 

 



 

Conclusion

 

                  The organization is focused on executing the business plan

 

                  Costs coming down – beds (organic growth & acquisitions) increasing

 

                  Technology initiatives will further improve productivity and efficiency

 

                  Company well positioned for MMA in 2006

 

                  The plan is working

 



 

Redefining
Service

 

[LOGO]

 

2005 UBS Global Healthcare Services Conference

John J. Arlotta, Chairman, President & CEO

February 16, 2005